VIVS
Price:
$0.3449
Market Cap:
$885.92K
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech co...[Read more]
Industry
Biotechnology
IPO Date
2012-02-14
Stock Exchange
NASDAQ
Ticker
VIVS
According to VivoSim Labs, Inc.’s latest financial reports and current stock price. The company's current ROE is -277.62%. This represents a change of -378.98% compared to the average of 99.51% of the last 4 quarters.
The mean historical ROE of VivoSim Labs, Inc. over the last ten years is 35.17%. The current -277.62% ROE has changed -889.35% with respect to the historical average. Over the past ten years (40 quarters), VIVS's ROE was at its highest in in the March 2026 quarter at 524.48%. The ROE was at its lowest in in the December 2024 quarter at -946.98%.
Average
35.17%
Median
-65.95%
Minimum
-407.41%
Maximum
1.26%
Discovering the peaks and valleys of VivoSim Labs, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 261.86%
Maximum Annual ROE = 1.26%
Minimum Annual Increase = -5411.78%
Minimum Annual ROE = -407.41%
| Year | ROE | Change |
|---|---|---|
| 2026 | 1.26% | -5411.78% |
| 2025 | -23.71% | -94.18% |
| 2024 | -407.41% | 261.86% |
| 2023 | -112.59% | 197.10% |
| 2022 | -37.90% | -11.72% |
| 2021 | -42.93% | -38.90% |
| 2020 | -70.26% | -4.25% |
| 2019 | -73.38% | -5.99% |
| 2018 | -78.06% | 26.61% |
| 2017 | -61.65% | -0.62% |
The current ROE of VivoSim Labs, Inc. (VIVS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
276.16%
5-year avg
135.60%
10-year avg
35.17%
VivoSim Labs, Inc.’s ROE is greater than Quoin Pharmaceuticals, Ltd. (-292.33%), greater than Pasithea Therapeutics Corp. (-57.44%), greater than Cyclerion Therapeutics, Inc. (-62.10%), greater than Alaunos Therapeutics, Inc. (-165.94%), less than PharmaCyte Biotech, Inc. (-0.00%), greater than Polyrizon Ltd. (-16.94%), less than NovaBay Pharmaceuticals, Inc. (1.72%), greater than Radiopharm Theranostics Limited (-93.08%), greater than XTL Biopharmaceuticals Ltd. (-269.02%), greater than Impact BioMedical Inc. (-2674.57%),
| Company | ROE | Market cap |
|---|---|---|
| -292.33% | $8.58M | |
| -57.44% | $3.35M | |
| -62.10% | $15.16M | |
| -165.94% | $4.64M | |
| -0.00% | $3.98M | |
| -16.94% | $13.11M | |
| 1.72% | $39.14M | |
| -93.08% | $4.06M | |
| -269.02% | $7.00M | |
| -2674.57% | $5.33M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VivoSim Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VivoSim Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is VivoSim Labs, Inc.'s ROE?
How is the ROE calculated for VivoSim Labs, Inc. (VIVS)?
What is the highest ROE for VivoSim Labs, Inc. (VIVS)?
What is the 3-year average ROE for VivoSim Labs, Inc. (VIVS)?
What is the 5-year average ROE for VivoSim Labs, Inc. (VIVS)?
How does the current ROE for VivoSim Labs, Inc. (VIVS) compare to its historical average?